These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32756110)

  • 21. Vaccine-derived poliovirus surveillance in China during 2001-2013: the potential challenge for maintaining polio free status.
    Wang HB; Luo HM; Li L; Fan CX; Hao LX; Ma C; Su QR; Yang H; Reilly KH; Wang HQ; Wen N
    BMC Infect Dis; 2017 Dec; 17(1):742. PubMed ID: 29197328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An acute flaccid paralysis surveillance-based serosurvey of poliovirus antibodies in Western Uttar Pradesh, India.
    Bahl S; Gary HE; Jafari H; Sarkar BK; Pathyarch SK; Sethi R; Deshpande J
    J Infect Dis; 2014 Nov; 210 Suppl 1(Suppl 1):S234-42. PubMed ID: 25316841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is Italian population protected from Poliovirus? Results of a seroprevalence survey in Florence, Italy.
    Giammanco GM; Bechini A; Urone N; Bonura F; Li Muli S; De Grazia S; Bellini I; Tiscione E; Boccalini S; Nastasi A
    Hum Vaccin Immunother; 2018; 14(9):2248-2253. PubMed ID: 29771600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.
    Băicuş A; Persu A; Combiescu M; Aubert-Combiescu A
    Roum Arch Microbiol Immunol; 2007; 66(1-2):44-50. PubMed ID: 18928063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term persistence of poliovirus neutralizing antibodies in the era of polio elimination: An Italian retrospective cohort study.
    Bianchi FP; Larocca AMV; Bozzi A; Spinelli G; Germinario CA; Tafuri S; Stefanizzi P
    Vaccine; 2021 May; 39(22):2989-2994. PubMed ID: 33933314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survey of poliovirus antibodies during the final stage of polio eradication in Egypt.
    El-Sayed N; Al-Jorf S; Hennessey KA; Salama M; Watkins MA; Abdelwahab JA; Pallansch MA; Gary H; Wahdan MH; Sutter RW
    Vaccine; 2007 Jun; 25(27):5062-70. PubMed ID: 17543428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poliovirus antibody levels and lameness among individuals in three regions of Ghana.
    Opare JKL; Odoom JK; Akweongo P; Afari EA; Pappoe M
    Hum Vaccin Immunother; 2019; 15(9):2050-2059. PubMed ID: 31265356
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunogenicity of poliovirus vaccines in chronically malnourished infants: a randomized controlled trial in Pakistan.
    Saleem AF; Mach O; Quadri F; Khan A; Bhatti Z; Rehman NU; Zaidi S; Weldon WC; Oberste SM; Salama M; Sutter RW; Zaidi AK
    Vaccine; 2015 Jun; 33(24):2757-63. PubMed ID: 25917673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seroprevalence of antipolio antibodies among children <15 years of age in border provinces in China.
    Wang H; Cui H; Ding Z; Ba P; Zhu S; Wen N; Hao L; Ning J; Zhang J; Yang D; Xu W; Zhang Y; Fan C; Yu W; Liang X; Luo H
    Clin Vaccine Immunol; 2013 Jul; 20(7):1070-5. PubMed ID: 23677325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria.
    Giwa FJ; Olayinka AT; Ogunshola FT
    Vaccine; 2012 Nov; 30(48):6759-65. PubMed ID: 23000220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroprevalence of poliovirus antibodies among 7-month-old infants after 4 doses of oral polio vaccine in Sistan-va-Baluchestan, Islamic Republic of Iran.
    Izadi S; Shahmahmoodi S; Zahraei SM; Dorostkar F; Majdzadeh SR
    East Mediterr Health J; 2015 Apr; 21(2):83-9. PubMed ID: 25876819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroprevalence of poliovirus antibodies before and after polio vaccine switch in 2012 and 2017 in Beijing.
    Li J; Zhang Z; Zhang H; Li M; Li X; Lu L; Huang F; Wu J
    Hum Vaccin Immunother; 2021 Feb; 17(2):389-396. PubMed ID: 32703060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is EU/EEA population protected from polio?
    Nijsten D; Carrillo-Santisteve P; Miglietta A; Ruitenberg J; Lopalco PL
    Hum Vaccin Immunother; 2015; 11(9):2123-31. PubMed ID: 25898095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polio eradication in Nigeria: evaluation of the quality of acute flaccid paralysis surveillance documentation in Bauchi state, 2016.
    Ningi AI; Shuaib F; Ibrahim LM; Saleh JA; Abdelrahim K; Bello IM; Abba B; Muluh TJ; Braka F; Tegegne SG; Wallah A; Korir C; Bawa S; Saidu M; Nsubuga P
    BMC Public Health; 2018 Dec; 18(Suppl 4):1307. PubMed ID: 30541495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Environmental Surveillance Complements Case-Based Surveillance of Acute Flaccid Paralysis in Polio Endgame Strategy 2019-2023.
    Chen P; Liu Y; Wang H; Liu G; Lin X; Zhang W; Ji F; Xu Q; Tao Z; Xu A
    Appl Environ Microbiol; 2020 Jul; 86(15):. PubMed ID: 32444474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RAPID COMMUNICATION-- POLIO VACCINE COVERAGE IN THE ACUTE FLACCID PARALYSIS (AFP) CASES IN ROMANIA.
    Băicuş A
    Roum Arch Microbiol Immunol; 2015; 74(1-2):65-7. PubMed ID: 26727855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-Term Immunogenicity of Inactivated and Oral Polio Vaccines: An Italian Retrospective Cohort Study.
    Larocca AMV; Bianchi FP; Bozzi A; Tafuri S; Stefanizzi P; Germinario CA
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poliovirus Immunity among Children Aged 6-11 and 36-48 Months in 14 Polio High-Risk Provinces of Afghanistan: A Health-Facility-Based Study.
    Soofi SB; Martinez M; Farag NH; Hendley WS; Ehrhardt D; Ahmed I; Hussain I; Weldon W; Kassem AM
    Vaccines (Basel); 2022 Oct; 10(10):. PubMed ID: 36298591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity of Different Routine Poliovirus Vaccination Schedules: A Randomized, Controlled Trial in Karachi, Pakistan.
    Saleem AF; Mach O; Yousafzai MT; Khan A; Weldon WC; Steven Oberste M; Zaidi SS; Alam MM; Quadri F; Sutter RW; Zaidi AKM
    J Infect Dis; 2018 Jan; 217(3):443-450. PubMed ID: 29126173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced surveillance of acute flaccid paralysis following importation of wild poliovirus in Xinjiang Uygur Autonomous Region, China.
    Wen N; Fan CX; Fu JP; Ning J; Ji YX; Luo HM; Wang HQ; Zhu SL; Yu WZ; Wang HB; Zhu H; Cui FQ; Li DX; Wang SW; Xu WB; Hao LX; Cao LS; Luo L; Han L; Cao L; Xia W; Wang XQ; Reilly KH; Wushouer F; Mi SS; Yang WZ; Li L
    BMC Infect Dis; 2014 Feb; 14():113. PubMed ID: 24576083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.